Oncolys BioPharma Inc.
TSE:4588.T
905 (JPY) • At close November 12, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -1,938.505 | -1,146.005 | -1,611.714 | -2,091.359 | -908.593 | -1,230.105 | -1,087.185 | -928.344 | -854.701 | -737.106 | -633.193 | -100.513 |
| Afschrijvingen & Amortisatie
| 2.286 | 0.914 | 6.486 | 4.89 | 3.109 | 1.709 | 1.162 | 15.364 | 16.764 | 12.551 | 17.139 | 16.953 |
| Uitgestelde Inkomstenbelasting
| 156.328 | 0 | 61.68 | 377.399 | 364.059 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 9.433 | 58.134 | 208.951 | 376.608 | 125.928 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| 552.413 | -501.782 | -532.585 | -129.755 | 148.733 | 37.036 | 13.429 | -60.245 | 93.755 | -65.494 | 8.844 | -107.876 |
| Vorderingen
| 151.426 | 98.079 | -208.637 | 1.867 | -118.924 | 38.352 | -22.885 | -65.04 | 29.936 | 0 | 0 | 0 |
| Voorraden
| 18.907 | -12.593 | -1.183 | 4.444 | -3.855 | 7.519 | -3.463 | 0.592 | 3.07 | 2.832 | -3.561 | 0.795 |
| Crediteuren
| 0 | -98.079 | 208.637 | -1.867 | 118.924 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 382.08 | -489.189 | -531.402 | -134.199 | 152.588 | 29.517 | 16.892 | -60.837 | 90.685 | -68.326 | 12.405 | -108.671 |
| Overige Niet-Contante Posten
| -118.877 | -128.396 | 125.355 | -2.982 | 28.536 | 3.781 | -24.246 | 69.801 | -11.574 | -24.44 | 8.682 | 40.087 |
| Kasstroom uit Operationele Activiteiten
| -1,336.922 | -1,717.135 | -1,741.827 | -1,465.199 | -238.228 | -1,187.579 | -1,096.84 | -903.424 | -755.756 | -814.489 | -598.528 | -151.349 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -5.686 | -1.358 | -1.437 | -2.7 | -4.29 | -1.643 | -1.436 | -20.994 | -4.175 | -23.085 | -0.678 | -15.374 |
| Netto Overnames
| 0.136 | 0 | 0 | -10.763 | 0 | 0 | -11.079 | -10.173 | 4.175 | 9.877 | 0 | -10.86 |
| Aankoop van Beleggingen
| -0.001 | -0.001 | -0.001 | -0.006 | -0.006 | -356.316 | -455.676 | -512.638 | -245.236 | -3,545.016 | -75 | -417.12 |
| Verkoop/verval van Beleggingen
| 0 | 0 | 0.486 | -21.762 | 0 | 700 | 600 | 798.591 | 2,000 | 175 | 187.138 | 172.879 |
| Overige Investeringsactiviteiten
| 0.159 | 21.476 | 0.01 | -2.346 | -0.146 | -0.001 | -0.147 | 1.841 | 0.044 | -25.478 | -1.002 | -0.879 |
| Kasstroom uit Investeringsactiviteiten
| -5.392 | 20.117 | -0.942 | -37.577 | -4.442 | 342.04 | 131.662 | 256.627 | 1,754.808 | -3,408.702 | 110.458 | -271.354 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 1,241.526 | 0 | 3,085.424 | 245.505 | 1,006.892 | 1,188.328 | 1,409.382 | 36.878 | 0.12 | 5.66 | 5,232.936 | 255.905 |
| Terugkoop van Gewone Aandelen
| 0 | -0.028 | -0.036 | -0.095 | 0 | 0 | 0 | 0 | 0 | -15.124 | -25.024 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -35.074 | -240.171 | 0 |
| Overige Financieringsactiviteiten
| 18.076 | -2.698 | 225.619 | 193.704 | 194.204 | 2.278 | 92.547 | 2.865 | -6.844 | 74.447 | 500.34 | 128.046 |
| Kasstroom uit Financieringsactiviteiten
| 1,142.542 | -113.83 | 3,091.384 | 242.261 | 1,123.312 | 1,147.27 | 1,476.503 | 6.423 | -120.06 | -0.233 | 5,440.081 | 362.451 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 21.334 | 67.413 | 38.171 | -14.147 | -1.201 | -6.111 | -7.864 | -0.885 | -1.204 | 1.28 | 28.743 | 1.44 |
| Netto Kasstroomverandering
| -178.438 | -1,743.434 | 1,386.785 | -1,274.664 | 879.44 | 295.62 | 503.461 | -641.259 | 877.786 | -4,222.144 | 4,980.755 | -54.953 |
| Kaspositie aan het Einde van de Periode
| 1,287.763 | 1,466.201 | 3,209.635 | 1,822.85 | 3,097.514 | 2,218.074 | 1,922.454 | 1,418.993 | 2,060.252 | 1,182.466 | 5,404.61 | 423.855 |